TrialCancer medicine2024

Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study.

Wen-Jin Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.